CORE--PEDIATRIC SICKLE CELL PROGRAM

核心--儿科镰状细胞项目

基本信息

  • 批准号:
    6456260
  • 负责人:
  • 金额:
    $ 22.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-04-01 至 2002-03-31
  • 项目状态:
    已结题

项目摘要

The pediatric clinical core provides comprehensive care for 235 children, teenagers, and young adults with sickle cell disease (SCD) in 222 families . The pediatric clinical care component of patient services is a system of high quality, readily available medical and psychosocial care that responds to the patient's needs. Our multidisciplinary approach integrates the skills of medical subspecialists, social workers, counselors, psychologists, and nurses to meet the patient's and family's needs. The majority of the patients in this program are born in the Greater Cincinnati area and are identified by newborn screening. The Cincinnati Comprehensive Sickle Cell Center (CCSCC) continues to take a leadership role in insuring appropriate and timely follow-up for infants born in this area. No baby in the Cincinnati area who was identified by newborn screening as having a sickle hemoglobinopathy has been lost to follow-up. The clinical care component works effectively with the primary care provider to coordinate care with a minimum of redundancy and maximum of benefits. The clinical care component emphasizes a smooth transition into adult care and addresses problems of education, vocational, and psychosocial aspects of this chronic disease. The clinical care component also serves to promote both clinical and basis research that may benefit patients with SCD. The specific aims of the Pediatric Clinical Core are 1) to provide comprehensive care to patients and families of patients enrolled in the pediatric clinic; 2) to adapt the traditional concept of comprehensive care to the present day reality of managed care by which patient enrolled in various managed health care plans continue to receive the benefits of a comprehensive program; 3) to provide training opportunities for residents, fellows, medical students, nursing students genetic counseling students, as well as other health care professionals; 4) to develop a transition clinic for adolescent patients as part of a transition program the goals of which are to help adolescents make a successful transition to an adult comprehensive care program; and 5) to maintain a stable resource of patients for the clinical and basic science research activities, and to provide clinical data for those projects.
儿科临床中心为235名儿童提供全面护理,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAREN A KALINYAK其他文献

KAREN A KALINYAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAREN A KALINYAK', 18)}}的其他基金

CLINICAL CORE
临床核心
  • 批准号:
    8150169
  • 财政年份:
    2010
  • 资助金额:
    $ 22.86万
  • 项目类别:
DIPYRIDAMOLE/MAGNESIUM TO IMPROVE SICKLE CELL HYDRATION
双嘧达莫/镁改善镰状细胞水合作用
  • 批准号:
    7607766
  • 财政年份:
    2007
  • 资助金额:
    $ 22.86万
  • 项目类别:
Dipyridamole/Magnesium to Improve Sickle Cell Hydration
双嘧达莫/镁改善镰状细胞水合作用
  • 批准号:
    6782210
  • 财政年份:
    2003
  • 资助金额:
    $ 22.86万
  • 项目类别:
Core--Clinical
核心--临床
  • 批准号:
    6782230
  • 财政年份:
    2003
  • 资助金额:
    $ 22.86万
  • 项目类别:
CORE--PEDIATRIC SICKLE CELL PROGRAM
核心--儿科镰状细胞项目
  • 批准号:
    6584670
  • 财政年份:
    2002
  • 资助金额:
    $ 22.86万
  • 项目类别:
CORE--PEDIATRIC SICKLE CELL PROGRAM
核心--儿科镰状细胞项目
  • 批准号:
    6667543
  • 财政年份:
    2002
  • 资助金额:
    $ 22.86万
  • 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的处理
  • 批准号:
    6584668
  • 财政年份:
    2002
  • 资助金额:
    $ 22.86万
  • 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的处理
  • 批准号:
    6667541
  • 财政年份:
    2002
  • 资助金额:
    $ 22.86万
  • 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的治疗
  • 批准号:
    6456258
  • 财政年份:
    2001
  • 资助金额:
    $ 22.86万
  • 项目类别:
MANAGEMENT OF SICKLE CELL VASO-0CCLUSIVE EPISODES
镰状细胞 VASO-0 闭塞性发作的治疗
  • 批准号:
    6325980
  • 财政年份:
    2000
  • 资助金额:
    $ 22.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了